British Columbia Investment Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Sell |
57,969
-14,288
| -20% | -$515K | 0.01% | 578 |
|
|
2025
Q1 | $2.25M | Sell |
72,257
-716
| -1% | -$22.3K | 0.01% | 596 |
|
|
2024
Q4 | $1.86M | Buy |
72,973
+8,824
| +14% | +$225K | 0.01% | 638 |
|
|
2024
Q3 | $1.81M | Sell |
64,149
-8,613
| -12% | -$244K | 0.01% | 626 |
|
|
2024
Q2 | $1.92M | Buy |
72,762
+27,553
| +61% | +$727K | 0.01% | 618 |
|
|
2024
Q1 | $1.37M | Buy |
45,209
+1,303
| +3% | +$39.6K | 0.01% | 658 |
|
|
2023
Q4 | $1.23M | Buy |
43,906
+9,252
| +27% | +$260K | 0.01% | 660 |
|
|
2023
Q3 | $941K | Buy |
34,654
+683
| +2% | +$18.5K | 0.01% | 652 |
|
|
2023
Q2 | $1.04M | Buy |
33,971
+2,555
| +8% | +$78.5K | 0.01% | 635 |
|
|
2023
Q1 | $1.13M | Buy |
31,416
+441
| +1% | +$15.9K | 0.01% | 609 |
|
|
2022
Q4 | $1.22M | Sell |
30,975
-3,471
| -10% | -$137K | 0.01% | 568 |
|
|
2022
Q3 | $1.38M | Sell |
34,446
-5,994
| -15% | -$241K | 0.02% | 535 |
|
|
2022
Q2 | $1.7M | Sell |
40,440
-12,604
| -24% | -$530K | 0.02% | 550 |
|
|
2022
Q1 | $2.07M | Sell |
53,044
-6,902
| -12% | -$269K | 0.01% | 647 |
|
|
2021
Q4 | $2.39M | Buy |
59,946
+27,325
| +84% | +$1.09M | 0.01% | 655 |
|
|
2021
Q3 | $1.18M | Buy |
32,621
+265
| +0.8% | +$9.58K | 0.01% | 786 |
|
|
2021
Q2 | $1.33M | Buy |
32,356
+3,733
| +13% | +$153K | 0.01% | 794 |
|
|
2021
Q1 | $1.25M | Buy |
28,623
+9,411
| +49% | +$411K | 0.01% | 766 |
|
|
2020
Q4 | $962K | Buy |
+19,212
| New | +$962K | 0.01% | 789 |
|